These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12685623)

  • 1. Accelerated plasminogen activator inhibitor may prevent late restenosis after coronary stenting in acute myocardial infarction.
    Inoue T; Yaguchi I; Mizoguchi K; Uchida T; Takayanagi K; Hayashi T; Morooka S; Eguchi Y
    Clin Cardiol; 2003 Mar; 26(3):153-7. PubMed ID: 12685623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new thrombolytic agent, monteplase, is independent of the plasminogen activator inhibitor in patients with acute myocardial infarction: initial results of the COmbining Monteplase with Angioplasty (COMA) trial.
    Inoue T; Yaguchi I; Takayanagi K; Hayashi T; Morooka S; Eguchi Y
    Am Heart J; 2002 Oct; 144(4):E5. PubMed ID: 12360174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis.
    Strauss BH; Lau HK; Bowman KA; Sparkes J; Chisholm RJ; Garvey MB; Fenkell LL; Natarajan MK; Singh I; Teitel JM
    Circulation; 1999 Oct; 100(15):1616-22. PubMed ID: 10517732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-month angiographic follow-up after intravascular ultrasound-guided stenting of infarct-related artery: comparison with non-infarct-related artery.
    Hong MK; Park SW; Lee CW; Rhee KS; Song JM; Kang DH; Song JK; Kim JJ; Park SJ
    Am Heart J; 2001 May; 141(5):832-6. PubMed ID: 11320374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relation of aortic stiffness and in-stent restenosis in patients undergoing percutaneous coronary stenting.
    Mahfouz RA; Abdulmoneim A; Abduo M; Elawady W
    Echocardiography; 2013 May; 30(5):582-7. PubMed ID: 23565733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine stenting vs. balloon angioplasty in ST-segment elevation myocardial infarction due to proximal left anterior descending coronary artery occlusion.
    De Luca G; Suryapranata H; van't Hof AW; Ottervanger JP; Hoorntje JC; Dambrink JH; Gosselink AT; de Boer MJ
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):22-6. PubMed ID: 19145115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provisional stenting for multivessel PCI.
    Han B; Liu L; Aboud M; Nahir M; Hasin Y
    Int J Cardiovasc Intervent; 2005; 7(1):46-51. PubMed ID: 16019615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study.
    Serruys PW; Foley DP; Suttorp MJ; Rensing BJ; Suryapranata H; Materne P; van den Bos A; Benit E; Anzuini A; Rutsch W; Legrand V; Dawkins K; Cobaugh M; Bressers M; Backx B; Wijns W; Colombo A
    J Am Coll Cardiol; 2002 Feb; 39(3):393-9. PubMed ID: 11823075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction.
    Cagliyan CE; Yuregir OO; Balli M; Tekin K; Akilli RE; Bozdogan ST; Turkmen S; Deniz A; Baykan OA; Aslan H; Cayli M
    Coron Artery Dis; 2013 May; 24(3):196-200. PubMed ID: 23283030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of plasma plasminogen activator inhibitor-1 for coronary restenosis: dependence on stent implantation and antithrombotic medication.
    Christ G; Nikfardjam M; Huber-Beckmann R; Gottsauner-Wolf M; Glogar D; Binder BR; Wojta J; Huber K
    J Thromb Haemost; 2005 Feb; 3(2):233-9. PubMed ID: 15670026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very late in-stent restenosis (five years) presenting as an ST elevation acute myocardial infarction.
    Bertrand OF; Rodés-Cabau J; Poirier P
    Can J Cardiol; 2004 Dec; 20(14):1481-3. PubMed ID: 15614345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct drug-eluting stenting to reduce stent restenosis: a randomized comparison of direct stent implantation to conventional stenting with pre-dilation or provisional stenting in elective PCI patients.
    Remkes WS; Somi S; Roolvink V; Rasoul S; Ottervanger JP; Gosselink AT; Hoorntje JC; Dambrink JH; de Boer MJ; Suryapranata H; van 't Hof AW;
    JACC Cardiovasc Interv; 2014 Jul; 7(7):751-8. PubMed ID: 25060017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the clinical efficacy of recombinant tissue-type plasminogen activator thrombolysis with primary coronary stenting in acute myocardial infarction].
    Chen B; Wang W; Zhao H; Zhao M; Hubayi ; Xu CD; Lu M
    Zhonghua Nei Ke Za Zhi; 2002 Jan; 41(1):21-3. PubMed ID: 11940291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of preprocedural fibrinogen concerning coronary stenting.
    Otsuka M; Hayashi Y; Ueda H; Imazu M; Kohno N
    Atherosclerosis; 2002 Oct; 164(2):371-8. PubMed ID: 12204810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a short antibiotic treatment with roxithromycin on circulating adhesion molecules after coronary stenting: a single-center pilot trial.
    Vandoni P; Morelli B; Lazzati L; Citterio R; Poli A; Fetiveau R; D'Urbano M; Cafiero F; Viganò E; De Servi S
    Ital Heart J; 2004 Sep; 5(9):667-72. PubMed ID: 15568594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen after coronary angioplasty as a risk factor for restenosis.
    Montalescot G; Ankri A; Vicaut E; Drobinski G; Grosgogeat Y; Thomas D
    Circulation; 1995 Jul; 92(1):31-8. PubMed ID: 7788913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late clinical and angiographic follow-up after stenting in evolving and recent myocardial infarction.
    Le May MR; Labinaz M; Marquis JF; O'Brien ER; Beanlands RS; Laramée LA; Williams WL; Davies RF; Kearns SA; Higginson LA
    Am Heart J; 1998 Apr; 135(4):714-8. PubMed ID: 9539491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct coronary stent implantation does not reduce the incidence of in-stent restenosis or major adverse cardiac events: six month results of a randomized trial.
    IJsselmuiden AJ; Serruys PW; Scholte A; Kiemeneij F; Slagboom T; vd Wieken LR; Tangelder GJ; Laarman GJ
    Eur Heart J; 2003 Mar; 24(5):421-9. PubMed ID: 12633544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis.
    Naruko T; Ueda M; Ehara S; Itoh A; Haze K; Shirai N; Ikura Y; Ohsawa M; Itabe H; Kobayashi Y; Yamagishi H; Yoshiyama M; Yoshikawa J; Becker AE
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):877-83. PubMed ID: 16469945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
    Soeki T; Tamura Y; Fukuda N; Ito S
    Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.